Finance

Lists
AUTL:NASDAQ
Autolus Therapeutics PLC
1,59 $
-0,62%
(-0,0100) 1D
1,59 $
0,00% (0,00)
After hours
Closed: 19 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUTL...
Open
1,59 $
High
1,60 $
Low
1,54 $
Mkt. cap
423,20 մլն
Avg. vol.
1,67 մլն
Volume
1,52 մլն
52-wk high
2,58 $
52-wk low
1,18 $
EPS
-1,05 $
Beta
2,15
Shares outstanding
266,16 մլն
No. of employees
753
Open
1,59 $
High
1,60 $
Low
1,54 $
Mkt. cap
423,20 մլն
Avg. vol.
1,67 մլն
Volume
1,52 մլն
52-wk high
2,58 $
52-wk low
1,18 $
EPS
-1,05 $
Beta
2,15
Shares outstanding
266,16 մլն
No. of employees
753
News stories
From web sources and news partners
About Autolus Therapeutics PLC
CEOChristian Itin
Employees753
Founded2014
Headquarters-
Sector-
Websiteautolus.com
Analyst ratings
Based on 5 analysts giving stock ratings to AUTL in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for AUTL in the last 3 months.
Highest
Current 1,59 $
10,00 $ (+528,93%)
Average
7,70 $ (+384,28%)
Lowest
5,00 $ (+214,47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
10,00 $
+528,9%
10/02/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
5,00 $
+214,5%
10/02/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/25/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
10,00 $
+528,9%
09/21/2026
Rajan Sharma
Goldman Sachs
Buy
Reiterated
5,80 $
+264,8%
08/11/2026
Salim Syed
Mizuho Securities
Buy
Maintained
10,00 $
+528,9%
06/10/2026
Unknown Analyst
Goldman Sachs
Buy
Reiterated
5,40 $
+239,6%
05/15/2026
Last report
11 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,15 $ / -0,19 $
+19,64%beat
Revenue / Est. (USD)
45,69 մլն / 40,15 մլն
+13,79%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
21,19 մլն
24,29 մլն
26,22 մլն
45,69 մլն
Cost of goods sold
56,54 մլն
54,29 մլն
45,78 մլն
48,37 մլն
Cost of revenue
56,54 մլն
54,29 մլն
45,78 մլն
48,37 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,28 մլն
42,12 մլն
39,95 մլն
41,16 մլն
Operating expense
36,28 մլն
42,12 մլն
39,95 մլն
41,16 մլն
Total operating expenses
92,82 մլն
96,41 մլն
85,73 մլն
89,53 մլն
Operating income
-71,62 մլն
-72,12 մլն
-59,51 մլն
-43,84 մլն
Other non operating income
84,00 հզր
-11,66 մլն
100,00 հզր
15,35 մլն
EBT including unusual items
-78,59 մլն
-91,52 մլն
-70,74 մլն
-38,65 մլն
EBT excluding unusual items
-78,59 մլն
-91,17 մլն
-70,74 մլն
-38,65 մլն
Income tax expense
532,00 հզր
-1,18 մլն
863,00 հզր
465,00 հզր
Effective tax rate
-0,68%
1,29%
-1,22%
-1,20%
Other operating expenses
-
-
-
-
Net income
-79,12 մլն
-90,33 մլն
-71,60 մլն
-39,11 մլն
Net profit margin
-373,30%
-371,90%
-273,09%
-85,60%
Earnings per share
-0,30
-0,34
-0,27
-0,15
Interest and investment income
4,38 մլն
3,23 մլն
2,47 մլն
1,88 մլն
Interest expense
-10,52 մլն
-11,01 մլն
-11,12 մլն
-12,50 մլն
Net interest expenses
-6,14 մլն
-7,78 մլն
-8,66 մլն
-10,62 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-69,08 մլն
-69,49 մլն
-56,81 մլն
-41,19 մլն
Gain or loss from assets sale
-
11,00 հզր
2,00 հզր
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps